FR2887749B1 - Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets des affections articulaires - Google Patents

Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets des affections articulaires

Info

Publication number
FR2887749B1
FR2887749B1 FR0551811A FR0551811A FR2887749B1 FR 2887749 B1 FR2887749 B1 FR 2887749B1 FR 0551811 A FR0551811 A FR 0551811A FR 0551811 A FR0551811 A FR 0551811A FR 2887749 B1 FR2887749 B1 FR 2887749B1
Authority
FR
France
Prior art keywords
prevention
effects
control
food supplement
joint diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0551811A
Other languages
English (en)
Other versions
FR2887749A1 (fr
Inventor
Jean Luc Charagnac
Cedric Bourges
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Nutreov SAS
Original Assignee
PHYSCIENCE SOC PAR ACTIONS SIM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHYSCIENCE SOC PAR ACTIONS SIM filed Critical PHYSCIENCE SOC PAR ACTIONS SIM
Priority to FR0551811A priority Critical patent/FR2887749B1/fr
Priority to FR0510167A priority patent/FR2887748B1/fr
Priority to PCT/FR2006/001512 priority patent/WO2007003762A1/fr
Publication of FR2887749A1 publication Critical patent/FR2887749A1/fr
Application granted granted Critical
Publication of FR2887749B1 publication Critical patent/FR2887749B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
FR0551811A 2005-06-29 2005-06-29 Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets des affections articulaires Active FR2887749B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0551811A FR2887749B1 (fr) 2005-06-29 2005-06-29 Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets des affections articulaires
FR0510167A FR2887748B1 (fr) 2005-06-29 2005-10-05 Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets des affections articulaires.
PCT/FR2006/001512 WO2007003762A1 (fr) 2005-06-29 2006-06-28 Complément alimentaire et son utilisation pour la prévention ou la lutte contre les effets des affections articulaires

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0551811A FR2887749B1 (fr) 2005-06-29 2005-06-29 Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets des affections articulaires

Publications (2)

Publication Number Publication Date
FR2887749A1 FR2887749A1 (fr) 2007-01-05
FR2887749B1 true FR2887749B1 (fr) 2009-09-04

Family

ID=35841730

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0551811A Active FR2887749B1 (fr) 2005-06-29 2005-06-29 Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets des affections articulaires

Country Status (1)

Country Link
FR (1) FR2887749B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2949044B1 (fr) 2009-08-12 2021-05-07 Expanscience Lab Composition comprenant une fraction d'insaponifiable

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744161A (en) * 1995-02-24 1998-04-28 Sabinsa Corporation Use of piperine as a bioavailability enhancer
JP4391673B2 (ja) * 2000-08-08 2009-12-24 花王株式会社 油脂組成物
US6455078B1 (en) * 2000-10-18 2002-09-24 Tzu-Sheng Wu Medicinal herbal composition for treating liver diseases and HIV
US6933291B2 (en) * 2000-12-01 2005-08-23 N.V. Nutricia Cholesterol lowering supplement
US6596313B2 (en) * 2001-08-06 2003-07-22 The Quigley Corporation Nutritional supplement and methods of using it
NZ537821A (en) * 2002-08-06 2007-05-31 The Quigley Corp Anti-viral compositions useful for treating one or more adverse effects of viral infections

Also Published As

Publication number Publication date
FR2887749A1 (fr) 2007-01-05

Similar Documents

Publication Publication Date Title
PL2118074T3 (pl) Związki chemiczne do celów profilaktyki i leczenia chorób układu sercowo-naczyniowego
PL2463283T3 (pl) Skondensowane fenyloamidowe związki heterocykliczne do zapobiegania i leczenia chorób pośredniczonych przez glukokinazę
IL193473A0 (en) Amide derivatives and their application for the treatment of g protein related diseases
HK1166983A1 (zh) 包含用於治療疾病或紊亂的化合物的固體形式，其組合物，及其用途
IL207713A0 (en) Formulation and method for the prevention and treatment of bone metastases or other bone diseases
WO2008076954A3 (fr) Composés hétérocycliques et procédés d'utilisation de ceux-ci
IL197148A0 (en) Methods and compositions for the treatment of antibody mediated neuropathies
EP2210092A4 (fr) Compositions comprenant des sémaphorines pour le traitement de maladies associées à l'angiogenèse et leurs procédés de sélection
NO20054798D0 (no) Prosessert fettpreparat for forebygging/bedring av livsstils-relaterte sykdommer
LT2100508T (lt) Augalų ligų kontrolės kompozicija ir būdas skirtas augalų ligų prevencijai ir kontrolei
EP2217238A4 (fr) Procédés et compositions pour le traitement de maladies protéinuriques
EP2182978A4 (fr) Kallikréine tissulaire destinée au traitement de maladies associées à la protéine amyloïde
HK1171972A1 (zh) 治療疾病的方法和產品
WO2010077339A3 (fr) Effecteurs de la β-arrestine, compositions en contenant et leurs procédés d'utilisation
FI20095600A (fi) Koostumus ihosairauksien hoitoa varten
WO2008131431A3 (fr) Modulation de l'expression des protéines de la barrière hémato-encéphalique
IL194880A (en) Aminazole amine derivatives, their use in the treatment of diseases and pharmaceuticals containing them
EP2240193A4 (fr) Composition renfermant des extraits de lindera obtusiloba pour la prévention et le traitement de maladies cardio-vasculaires
FR2906109B1 (fr) Complement alimentaire pour la prevention et la lutte contre les infections urinaires
FR2908604B1 (fr) Complement alimentaire pour la prevention ou la lutte contre la chute des cheveux, l'acne, l'hirsutisme et la secretion sudorale apocrine excessive.
EP2231148A4 (fr) Composition pharmaceutique utilisée dans le traitement et la prévention d'une maladie cardiaque
PL2234631T3 (pl) Związki i metody stosowane w terapii choroby naczyniowej
FR2887748B1 (fr) Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets des affections articulaires.
EP2231146A4 (fr) Composition pharmaceutique pour le traitement et la prévention du glaucome
PL1912513T3 (pl) Nowe frakcje białek mleka i ich zastosowanie do zapobiegania lub leczenia przewlekłych chorób zapalnych

Legal Events

Date Code Title Description
TP Transmission of property
CD Change of name or company name

Owner name: LABORATOIRES NUTREOV, FR

Effective date: 20120323

TP Transmission of property

Owner name: LABORATOIRES NUTREOV, FR

Effective date: 20120323

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19